Moneycontrol PRO
HomeNewsBusinessEarningsAlkem Laboratories net profit rises 4.2% to ₹305.9 crore in Q4FY25

Alkem Laboratories net profit rises 4.2% to ₹305.9 crore in Q4FY25

May 29, 2025 / 19:32 IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Alkem Laboratories Ltd. on Thursday reported a 4.2% year-on-year (YoY) rise in  fourth-quarter net profit (after minority interest) to ₹305.9 crore.

The Mumbai-based pharmaceutical company’s total revenue from operations for the fourth quarter grew by 7.1% year-on-year to ₹3143.8 crore.

For the fourth quarter, however, the EBITDA margin contracted to 12.4% from 13.7% in the same period last year.

The company’s India sales were a significant contributor, rising 8.1% to ₹2135.5 crore. International sales also saw an increase, growing by 7.2% to ₹974.7 crore.

For the full fiscal year, net profit climbed 20.6% to ₹2165.5 crore. Alkem’s total revenue from operations increased by a modest 2.3% to ₹12,964.5 crore. This was primarily driven by a 6.5% growth in India sales, which reached ₹8983.7 crore. However, international sales for the year saw a de-growth of 4.5%.

The company's EBITDA margin for the full year expanded by 170 basis points to 19.4%. Annual EBITDA increased by 11.9% to ₹2512.2 crore.

In the Indian market, Alkem's growth was 6.8% for the full year, compared to the Indian Pharmaceutical Market's (IPM) growth of 7.7%, according to IQVIA data. The company's acute segment outperformed the IPM by 30 basis points in FY25.

Research and development expenses for FY25 were 4.3% of total revenue. The company filed 9 abbreviated new drug applications (ANDAs) with the USFDA and received 14 approvals during the year.

The company's cash and bank balance stood at ₹4620 crore as of March 31, 2025.

Viswanath Pilla
Viswanath Pilla is a business journalist with 16 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
first published: May 29, 2025 07:31 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347